Cargando…

[(18)F]F13640, a 5-HT(1A) Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations

INTRODUCTION: Serotonin is involved in a variety of physiological functions and brain disorders. In this context, efforts have been made to investigate the in vivo fluctuations of this neurotransmitter using positron emission tomography (PET) imaging paradigms. Since serotonin is a full agonist, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colom, Matthieu, Vidal, Benjamin, Fieux, Sylvain, Redoute, Jérôme, Costes, Nicolas, Lavenne, Franck, Mérida, Inés, Irace, Zacharie, Iecker, Thibaud, Bouillot, Caroline, Billard, Thierry, Newman-Tancredi, Adrian, Zimmer, Luc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982540/ https://www.ncbi.nlm.nih.gov/pubmed/33762906 http://dx.doi.org/10.3389/fnins.2021.622423

Ejemplares similares

[(18)F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT(1A) receptors in humans
por: Courault, Pierre, et al.
Publicado: (2023)

Characterization and Reliability of [(18)F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT(6) Receptors
por: Sgambato-Faure, Véronique, et al.
Publicado: (2017)

CERMEP-IDB-MRXFDG: a database of 37 normal adult human brain [(18)F]FDG PET, T1 and FLAIR MRI, and CT images available for research
por: Mérida, Inés, et al.
Publicado: (2021)

Selective serotonin 5-HT(1A) receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study
por: Becker, G., et al.
Publicado: (2016)

Bayesian Estimation of the ntPET Model in Single-Scan Competition PET Studies
por: Irace, Zacharie, et al.
Publicado: (2020)

5-HT(1A )gene promoter polymorphism and [(18)F]MPPF binding potential in healthy subjects: a PET study
por: Lothe, Amélie, et al.
Publicado: (2010)

Marmoset Serotonin 5-HT(1A) Receptor Mapping with a Biased Agonist PET Probe (18)F-F13714: Comparison with an Antagonist Tracer (18)F-MPPF in Awake and Anesthetized States
por: Yokoyama, Chihiro, et al.
Publicado: (2016)

Design of CGMP Production of (18)F- and (68)Ga-Radiopharmaceuticals
por: Chi, Yen-Ting, et al.
Publicado: (2014)

[(18)F]Tosyl fluoride as a versatile [(18)F]fluoride source for the preparation of (18)F-labeled radiopharmaceuticals
por: Zhou, Dong, et al.
Publicado: (2023)

Multimodal imaging study of the 5-HT(1A) receptor biased agonist, NLX-112, in a model of L-DOPA-induced dyskinesia
por: Chaib, Sarah, et al.
Publicado: (2023)

Corrigendum to “Design of CGMP Production of (18)F- and (68)Ga-Radiopharmaceuticals”
por: Chi, Yen-Ting, et al.
Publicado: (2016)

Good practices for the automated production of (18)F-SiFA radiopharmaceuticals
por: Blok, Simon, et al.
Publicado: (2023)

Relationships between serotonin availability and frontolimbic response to fearful and threatening faces
por: Janet, R., et al.
Publicado: (2023)

A Fast and Simple Method for the Determination of TBA in (18)F-Labeled Radiopharmaceuticals
por: Halvorsen, Nils Erik, et al.
Publicado: (2020)

Concise and Scalable Radiosynthesis of (+)-[(18)F]MDL100907 as a Serotonin 5-HT(2A) Receptor Antagonist for PET
por: Chavan, Lahu N., et al.
Publicado: (2023)

Anti-aggressive effects of the selective high-efficacy ‘biased’ 5-HT(1A) receptor agonists F15599 and F13714 in male WTG rats
por: de Boer, Sietse F., et al.
Publicado: (2015)

3D-printed dual holder system for simultaneous rat PET scanning: design and influence on quantification
por: Bouillot, Caroline, et al.
Publicado: (2023)

(18)F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
por: Balogova, Sona, et al.
Publicado: (2013)

Serotonin 5-HT(4) receptor boosts functional maturation of dendritic spines via RhoA-dependent control of F-actin
por: Schill, Yvonne, et al.
Publicado: (2020)

Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease
por: Neumann, Joachim, et al.
Publicado: (2023)

Distribution of α(2)-Adrenergic Receptors in the Living Human Brain Using [(11)C]yohimbine PET
por: Laurencin, Chloé, et al.
Publicado: (2023)

Single subanesthetic dose of ketamine produces delayed impact on brain [(18)F]FDG PET imaging and metabolic connectivity in rats
por: Chaib, Sarah, et al.
Publicado: (2023)

Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) (18)F-Radiopharmaceuticals
por: Gower-Fry, Lexi, et al.
Publicado: (2021)

Targeted 5-HT(1F) Therapies for Migraine
por: Vila-Pueyo, Marta
Publicado: (2018)

Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [(11)C]-(R)-PK11195 PET and MRI
por: Yankam Njiwa, J, et al.
Publicado: (2016)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

(18)F-Labeled Silicon-Based Fluoride Acceptors: Potential Opportunities for Novel Positron Emitting Radiopharmaceuticals
por: Bernard-Gauthier, Vadim, et al.
Publicado: (2014)

Radioprotective efficacy of plastic polymer against the toxicogenomic effects of radiopharmaceutical (18)F-FDG on human lymphocytes
por: Lopes, Nilson Benedito, et al.
Publicado: (2020)

Embryo/Fetus Doses from (18)F-Fludeoxyglucose Radiopharmaceutical in Positron Emission Tomography/ Computed Tomography
por: Işıkçı, Nazenin İpek, et al.
Publicado: (2022)

Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT(3A) and 5-HT(6) receptor subtypes
por: Vitalis, Tania, et al.
Publicado: (2013)

An fMRI Study on the Role of Serotonin in Reactive Aggression
por: Krämer, Ulrike M., et al.
Publicado: (2011)

N-Benzylethanolammonium Ionic Liquids and Molten Salts in the Synthesis of (68)Ga- and Al(18)F-Labeled Radiopharmaceuticals
por: Kondratenko, Yulia A., et al.
Publicado: (2023)

Biophysical validation of serotonin 5-HT(2A) and 5-HT(2C) receptor interaction
por: Felsing, Daniel E., et al.
Publicado: (2018)

Conservation of 5-HT(1A) receptor-mediated autoinhibition of serotonin (5-HT) neurons in mice with altered 5-HT homeostasis
por: Araragi, Naozumi, et al.
Publicado: (2013)

Radiopharmaceuticals for therapy
por: Knapp, F F (Russ), et al.
Publicado: (2016)

PET Radiopharmaceuticals
por: Shahhosseini, Soraya
Publicado: (2011)

Pharmacovigilance in radiopharmaceuticals
por: Kumar, Rishi, et al.
Publicado: (2016)

Role of 2-[(18)F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review
por: Annunziata, Salvatore, et al.
Publicado: (2020)

Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
por: Alberts, Ian, et al.
Publicado: (2021)

3p-C-NETA: A versatile and effective chelator for development of Al(18)F-labeled and therapeutic radiopharmaceuticals
por: Ahenkorah, Stephen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v47athpev3oosvsakjdaue29ug